These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 33897885

  • 1. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C, Li X, Zhou M, Zhang S, Lai Q, Liu D, Ye B, Li L, Wu Y, Li H, Yue K, Chen P, Yao X, Wu Y, Duan Y, Wang X.
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [Abstract] [Full Text] [Related]

  • 2. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.
    Zhu R, Liu Y, Zhou H, Li L, Li Y, Ding F, Cao X, Liu Z.
    Cancer Lett; 2018 Apr 01; 418():125-134. PubMed ID: 29331416
    [Abstract] [Full Text] [Related]

  • 3. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
    Jing C, Duan Y, Zhou M, Yue K, Zhuo S, Li X, Liu D, Ye B, Lai Q, Li L, Yao X, Wei H, Zhang W, Wu Y, Wang X.
    Theranostics; 2021 Apr 01; 11(6):2655-2669. PubMed ID: 33456565
    [Abstract] [Full Text] [Related]

  • 4. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X, Zhu R, Luo A, Zhou H, Ding F, Yang H, Liu Z.
    J Exp Clin Cancer Res; 2020 Aug 31; 39(1):175. PubMed ID: 32867821
    [Abstract] [Full Text] [Related]

  • 5. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK, Liu LX, Zhang WY, Zhan HL, Chen RP, Feng JL, Wu LF.
    Oncol Rep; 2020 Nov 31; 44(5):2130-2142. PubMed ID: 32901893
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma.
    Yang Z, Liu H, Song Y, Gao N, Gao P, Hui Y, Li Y, Fan T.
    Int J Mol Med; 2024 Sep 31; 54(3):. PubMed ID: 38994756
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C, Shen S, Zheng X, Ye K, Ge H, Sun Y, Lu Y.
    FASEB J; 2020 May 31; 34(5):6055-6069. PubMed ID: 32239565
    [Abstract] [Full Text] [Related]

  • 12. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L, Zhao Z, Rong L, Xue L, Song Y.
    J Genet Genomics; 2019 Oct 20; 46(10):477-488. PubMed ID: 31812473
    [Abstract] [Full Text] [Related]

  • 13. OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.
    Zhou H, Liu Y, Zhu R, Ding F, Cao X, Lin D, Liu Z.
    Oncogene; 2018 Jun 20; 37(25):3356-3368. PubMed ID: 29559747
    [Abstract] [Full Text] [Related]

  • 14. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D, He X, Wang W, Hu X, Wang K, Wang M.
    Mol Oncol; 2020 Sep 20; 14(9):2332-2351. PubMed ID: 32239639
    [Abstract] [Full Text] [Related]

  • 15. SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis.
    Liu Y, Zhou H, Zhu R, Ding F, Li Y, Cao X, Liu Z.
    Oncogene; 2018 Feb 08; 37(6):768-776. PubMed ID: 29059170
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways.
    Song K, Ma C, Maswikiti EP, Gu B, Wang B, Wang N, Jiang P, Chen H.
    Mol Carcinog; 2024 Oct 08; 63(10):1892-1906. PubMed ID: 38923019
    [Abstract] [Full Text] [Related]

  • 17. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
    Seo D, Jung SM, Park JS, Lee J, Ha J, Kim M, Park SH.
    EBioMedicine; 2019 Nov 08; 49():55-71. PubMed ID: 31685442
    [Abstract] [Full Text] [Related]

  • 18. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B, Man H, Liu J, Wang L, Zhu T, Ma M, Xv Z, Chen X, Yang X, Li P.
    Oncol Rep; 2016 Sep 08; 36(3):1551-61. PubMed ID: 27430162
    [Abstract] [Full Text] [Related]

  • 19. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
    Nan P, Wang T, Li C, Li H, Wang J, Zhang J, Dou N, Zhan Q, Ma F, Wang H, Qian H.
    Carcinogenesis; 2020 Sep 24; 41(9):1263-1272. PubMed ID: 31783401
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.